Previously, the concentrations of IL-8 in the CSF of patients with ALS were measured and compared with those in patients with other non-inflammatory neurological diseases (such as AD and Parkinson’s disease), with those of patients with MS as positive controls. The gene discussed is CXCL8; the disease is myeloid sarcoma.